FDA delists hypertension med from VAT-exempt list
FDA delists hypertension med from VAT-exempt list is drawing significant interest across the industry.
A medicine for hypertension has been delisted by the Food and Drug Administration from the updated list of Value-Added Tax (VAT)-exempt health products.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- With Iran attack, Trump abandons a core tenet of his foreign policy
- Toyota Expands North America EV Lineup With Electric Highlander
- The Masked Singer stuns as it reveals Owl is Grammy-winning country music star whose kids are even more famous
- Fintech Postpones IPO As Software Sell-Off Spooks Investors
Source: Original →